It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Resistance to stress is a key determinant for mammalian functioning. While many studies have revealed neural circuits and substrates responsible for initiating and mediating stress responses, little is known about how the brain resists to stress and prevents overreactions. Here, we identified a previously uncharacterized neuropeptide Y (NPY) neuronal population in the dorsal raphe nucleus and ventrolateral periaqueductal gray region (DRN/vlPAG) with anxiolytic effects in male mice. NPYDRN/vlPAG neurons are rapidly activated by various stressful stimuli. Inhibiting these neurons exacerbated hypophagic and anxiety responses during stress, while activation significantly ameliorates acute stress-induced hypophagia and anxiety levels and transmits positive valence. Furthermore, NPYDRN/vlPAG neurons exert differential but synergic anxiolytic effects via inhibitory projections to the paraventricular thalamic nucleus (PVT) and the lateral hypothalamic area (LH). Together, our findings reveal a feedforward inhibition neural mechanism underlying stress resistance and suggest NPYDRN/vlPAG neurons as a potential therapeutic target for stress-related disorders.
Resistance to stress is vital for survival. Here the authors identify a group of anxiolytic NPY(NPYDRN/vlPAG) neurons that alleviate stress-induced hypophagia and anxiety, revealing a feedforward inhibition mechanism underlying stress resistance.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Fudan University, State Key Laboratory of Genetic Engineering, School of Life Sciences, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); Fudan University, Human Phenome Institute, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); University of Science and Technology of China, Hefei National Research center for Physical Sciences at the Microscale, Hefei, China (GRID:grid.59053.3a) (ISNI:0000 0001 2167 9639)
2 University of Science and Technology of China, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, Hefei, China (GRID:grid.59053.3a) (ISNI:0000 0001 2167 9639)
3 Fudan University, State Key Laboratory of Genetic Engineering, School of Life Sciences, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)
4 Hefei Comprehensive National Science Center, Institute of Artificial Intelligence, Hefei, China (GRID:grid.59053.3a)
5 National Institute of Biological Sciences, Beijing, China (GRID:grid.410717.4) (ISNI:0000 0004 0644 5086); Tsinghua University, Tsinghua Institute of Multidisciplinary Biomedical Research, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178)
6 University of Science and Technology of China, Hefei National Research center for Physical Sciences at the Microscale, Hefei, China (GRID:grid.59053.3a) (ISNI:0000 0001 2167 9639)
7 UNSW, St Vincent’s Centre for Applied Medical Research, Faculty of Medicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); University of New South Wales, Faculty of Medicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
8 Hefei Comprehensive National Science Center, Institute of Artificial Intelligence, Hefei, China (GRID:grid.1005.4)
9 University of Science and Technology of China, Hefei National Research center for Physical Sciences at the Microscale, Hefei, China (GRID:grid.59053.3a) (ISNI:0000 0001 2167 9639); University of Science and Technology of China, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, Hefei, China (GRID:grid.59053.3a) (ISNI:0000 0001 2167 9639)
10 Fudan University, State Key Laboratory of Genetic Engineering, School of Life Sciences, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); Fudan University, Human Phenome Institute, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); Fudan University, Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism & Integrative Biology, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); Zhongshan Hospital, Department of Endocrinology and Metabolism, Shanghai, China (GRID:grid.413087.9) (ISNI:0000 0004 1755 3939); Inner Mongolia University, School of Life Sciences, Hohhot, China (GRID:grid.411643.5) (ISNI:0000 0004 1761 0411)